• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

ImmInst Active Topics View Source: ImmInst Active Topics Last Updated: 20 May 2025 - 03:05 AM

HELP: 8y trying to get E. coli Nissle 1917 (MUTAFLOR) 18 May 2025 - 11:16 PM

Over the last 8 YEARS I've tried to get my hands on E. coli Nissle 1917 (MUTAFLOR) for its benefits on autoimmunity/HPA axis/gut issues, etc.

But the 4x I bought it, it was lost by the ¨#%&@¨$# Brazilian Mail service and arrived WAY too late, all bacteria as dead as nails the four times. (It's absurdly expensive by BR standards - and it must be kept refrigerated, so time's ticking as soon as it's sent).


:imminst: BACKGROUND: It's basically a supersoldier bacterial strain of (very) friendly E. coli that hunts down and destroys mercilessly a host of dysbiotic microbes, leading to hundreds of popular reports of complete remissions of dozens of types of autoimmune conditions, gut issues, skin conditions, and whatnot. 

 

Take a look at this study if you will: https://pmc.ncbi.nlm.nih.gov/articles/PMC5603654/ (Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction). 

There are dozens like it.

 

 

:imminst: RISE TO FAME: It's (in)famous for having been taken out of a soldier's arse in 1917 for having survived the trenches while everyone else died horribly of dysentery and also for having saved the life (or dearly improved the health) of Hitler as Dr. Morel, his personal physician, prescribed it to him in 1936.

 

:imminst: WHERE IT'S SOLD: AFAIK it's sold in Australia, NZ, Germany and perhaps a few Nordic countries (not in Sweden where I got extended family...) and not in Brazil (where I reside) and most of EU countries or US/Canada; It's got a bad legal status in most countries as it's a strain of E. coli and, therefore, considered a disease-causing bacteria (nonsense - this strain is extremely well-studied and ABSURDLY healthy/friendly).

 

:imminst: GETTING MUTAFLOR: I'm open to ANY way of getting MUTAFLOR. ANY idea/gimmick/hack that HELPs ME put my hands on this (still alive) strain of E Coli is deeply appreciated.


:imminst: HELP?: If any guy/gal from the Longecity community would be willing to help me get it/send it to me/whatever in some way that it would reach me alive, I'd appreciate it DEARLY...! It's being sh*t to stand these life-wrecking symptoms of autoimmunity and it could make a huge POSITIVE difference in my life quality.

As I said, I reside in Brazil, Porto Alegre, state of Rio Grande do Sul.



 



From the MUTAFLOR website

( https://www.mutaflor.com/mutaflor-clinically-proven-efficacy/introduction-and-overview.html )
 

According to current marketing authorizations (­Mutaflor, ­Mutaflor Suspension)
  •  Ulcerative colitis in the phase of remission
  •  Chronic constipation
  •  Colonization prophylaxis in premature and full-term infants
  •  Enhancement of postnatal immune competence in premature and full-term infants
  •  Diarrhea in infants, toddlers and children
  •  Diarrhea in infants, toddlers and children under gastric tube feeding
According to clinical studies
  • Crohn's disease
  • Pouchitis
  • Collagenous colitis
  • Antibiotic-associated colitis/pseudo-membranous colitis
  • Irritable bowel syndrome
  • Diverticulosis
  • Polymorphous photodermatosis
According to experiential reports/casuistics
  • Non-ulcer dyspepsia
  • Dietary intolerance/malabsorption
  • Halitosis
  • Susceptibility to infection
  • Mycoses of the gastrointestinal tract
  • Other, e. g. neurodermitis, reactive arthritis, radiation enteritis/radiation colitis, recurrent urinary tract infections
Overview of the pertinent studies

Diarrhea: Henker et al. 2007, 2008 39; 40
Irritable bowel syndrome: Krammer et al. 2006 52, Plassmann 2007 53, Keller et al. 2010 50, Kruis et al. 2012 29
Antibiotic-associated colitis/pseudomembranous colitis: Goerg u. Schlörer 1998 54, Goerg et al. 2008 55
Ulcerative colitis: Kruis et al. 1997 43, Rembacken et al. 1999 44, Kruis et al. 2004 45, Henker et al. 2008 46, Matthes et al. 2010 47
Crohn's disease: Malchow 1997 49
Pouchitis: Kuzela et al. 2001 56
Collagenous colitis: Tromm et al. 2004 57
Chronic constipation: Bruckschen et al. 1994 42, Möllenbrink et al. 1994 41
Diverticulosis of the colon: Fricˇ et al. 2003 58
Colonization prophylaxis and enhancement of immune competence in full-term and premature neonates: Lodinová-Žádníková et al. 1992 35, Lodinová-Žádníková und Sonnenborn 1997 36, Schröder 1992 3, Cukrowska et al. 2002 37
Intestinal-dependent halitosis: Henker et al. 2001 59
Polymorphous photodermatosis: Wurzel 1999 60

 

The beneficial, known and studied effects of the famous Gerovital H3 - Anti Aging Therapy 18 May 2025 - 01:18 PM

Gerovital H3 is the drug developed by Professor Dr. Ana Aslan in collaboration with pharmacist Elena Polovrageanu, based on observations at that time on the effects of procaine. Professor Daniel Danielopolu, who played an essential role in the creation of the Institute of Physiology, noted that procaine “restores and increases active vital processes and local resistance”, and Professor Dr. Ana Aslan intuited and discovered the biotrophic therapeutic actions of procaine, through long-term treatment in small doses, with a curative and prophylactic role.
 
The best known and studied effects of Gerovital H3 are the antioxidant and antidepressant effects.
 
Gerovital H3, through its active ingredient – ​​procaine, but also through its other ingredients (potassium metabisulfite, benzoic acid) exerts antioxidant action through several mechanisms, including direct inhibition of free radical generation and limitation of lipid peroxidation reactions of cell membranes.
 
Numerous studies have confirmed the role of procaine and Gerovital H3 as protective agents against oxidative stress: this role could explain the antiatherogenic effect and slowing down the effects of aging.
 
Chronic treatment with Gerovital H3 has antiatherosclerotic effects, a consequence of the reduction of cholesterol mobilized from deposits and of the lipotropic action, especially through its primary metabolite, diethylaminoethanol (DEAE).
 
Studies have also confirmed the “statin-like” action of procaine, exerted by regulating the activity of HMG-CoA-reductase, involved in cholesterol biosynthesis, with a decrease in total cholesterol and an increase in HDL cholesterol.
 
The antidepressant effect is exerted because Gerovital H3 is a weak, reversible and competitive monoamine oxidase inhibitor (MAOI) (which gives it reduced side effects compared to other MAOIs).
 
Other clinically proven effects are:
 
Reducing pain and improving mobility in patients with joint diseases, especially arthritic ones
 
Reducing stiffness and hypokinesia in syndromes and Parkinson's disease
 
Through all these beneficial effects, as well as through its use for more than 60 years, Gerovital H3 has proven its usefulness in the prevention and prophylaxis of some of the phenomena associated with aging. It is recommended to start treatments with Gerovital H3, administered in injectable or oral form, from the age of over 40 - 50, respecting the indications of the medicine's package insert, the indications of the doctor supervising the therapy, but also the preferences of each patient. Of great importance is the long-term treatment, under periodic monitoring, as long as there are no adverse reactions or contraindications, as well as respecting some lifestyle recommendations.
 
Dr. Gabriela Cirstescu
Geriatrician specialist, Anti-Aging Clinic
www.gerovitalcosmetic.com
www.gerovital-h3.com
www.originalgerovital.blogspot.com

Biomarkers For Slowing Eye Aging, Featuring ‪Doctor Eye Health‬ 18 May 2025 - 12:08 PM

Attached Thumbnails

  • Joe may thumb.png

Field Cryoprotection Available for CI Members | Aschwin de Wolf and Lauren Fosco 17 May 2025 - 07:49 PM

https://biostasis.substack.com/p/field-cryoprotection-available-for

 

 

Host:
 

Max More, Director of Communications, Biostasis Technologies

Guests:
 

Aschwin de Wolf, President & CEO, Biostasis Technologies.

Lauren Fosco, Chief Operating Officer, Biostasis Technologies. Director, Cryonics Institute.

Rudi Hoffman, Certified Financial Planner and leading insurance agent for cryonicists.
 

Suspended Animation Inc. (SA) has provided SST (standby, stabilization, and transport) to Cryonics Institute (CI) members for years. SST is a crucial part of the cryopreservation process. When a cryonics patient is not near the cryonics organization, there is an delay in getting them cryoprotected. Even with a blood washout before transport, ischemic injury will accumulate. By doing cryoprotection in the field – at the patient’s location – ischemic time can be greatly reduced, improving the quality of the cryopreservation.
 

Biostasis Technologies (BT) is not a cryonics service provider. BT offers help to all cryonics/biostasis organizations to improve protocols and advance research. This episode focuses on a new option for Cryonics Institute members.

In this discussion, you will learn answers to these questions:

  • What is the difference between cryoprotection and cryopreservation?

  • How is field cryoprotection (FCP) different from current CI/SA procedure?

  • Why are FCP patients shipped on dry ice? Why dry ice rather than ice? Why dry ice rather than liquid nitrogen?

  • Which cryoprotectant is used for FCP?

  • Do other cryonics organizations offer whole-body FCP?

  • What do you mean by true whole-body field cryoprotection?

  • Why is this better than existing SA SST procedures?

  • How do CI and SA cooperate to deliver SST/FCP?

  • Why are SST and FCP more expensive than CI membership itself?

  • I am already an SA client. What do I need to do?

  • How do I ensure that my funding allows for new future developments?

  • What funding level is appropriate for potential FCP expansion outside of the US?

  • How do I change amounts between beneficiaries in my existing policy?

  • Can I pay for the FCP upgrade in cash?

  • Where do the SST protocols originate and how are they monitored?

 

 

Which Epigenetic Clock Is Best For Evaluating Death Risk? 14 May 2025 - 11:27 AM

Attached Thumbnails

  • grim thumb.png

Mapping Our World The Power of Geospatial Technology 13 May 2025 - 08:26 AM

Hi everyone,

I've been reading Longecity for years, especially the tech and space discussions, and wanted to share a thought that often gets overlooked — the role of geospatial mapping technologies in both earthly and extraterrestrial exploration.

Today, GIS (Geographic Information Systems) has evolved far beyond traditional maps. It's now a crucial tool for visualizing how cities grow, how land is utilized, and how environments shift over time. These same technologies are becoming essential in simulating Martian surfaces and even mapping moons or exoplanets.

For instance, while working on regional mapping platforms for Pakistan, I’ve seen firsthand how interactive country-level maps can help visualize urban sprawl and infrastructure planning. On the historical side, projects that combine antique map overlays with modern GIS give us fascinating insights into how landscapes have evolved across centuries — a method that’s surprisingly relevant for planetary geology as well.

What fascinates me is how these earth-focused technologies are quietly laying the groundwork for future space colonization and resource mapping beyond our planet.

What’s your take?
Do you think GIS tools developed for urban planning and land visualization here on Earth will directly influence how we map and navigate space environments in the next decade?

Would love to hear your insights.

Greetings from Sydney 12 May 2025 - 03:11 PM

Greetings from Sydney

Piracetam maximum dosage per tablet? 12 May 2025 - 08:34 AM

Hi,

I'm interested to find a product with the maximum dosage of Piracetam per tablet or injection (vial).

Does anyone know of any product?

GPT-o4: chances of revival breakthroughs & when 11 May 2025 - 05:30 PM

Your decision to undergo cryopreservation reflects a long-term bet on science, technology, and human ingenuity. It’s a bold choice—and while it's speculative, it's not unreasonable to imagine that revival might someday be possible. But we should be honest: the barriers are immense, and a specific timeline is nearly impossible to predict with confidence.

Here’s a grounded breakdown:

Why It’s Not Entirely Unreasonable
  1. Exponential Technology Growth: Medical and computational advancements have grown rapidly. Consider the pace of progress in genomics, brain-computer interfaces, synthetic biology, and now AI-accelerated science.

  2. AI Acceleration: AI already helps design proteins (e.g., AlphaFold), simulate molecules, and model biological processes at previously impossible scales. Future AI might help decode and repair cryopreserved tissues or model a brain's structure from damaged or frozen matter.

  3. Nanotechnology Potential: Eric Drexler and others have speculated that future nanomachines might one day repair cellular damage at a molecular level—exactly what’s needed for cryonics to work.

Why It’s Still a Huge Leap
  1. No Known Successful Revival (Even of Simple Organisms): We haven’t yet revived a complex organism (like a mammal) from true cryopreservation, much less a human.

  2. Structural Damage from Freezing: Even with vitrification (glass-like freezing), ice formation and fracturing cause damage that may be irreparable without future technology.

  3. Information Theory of Death: If key neural structures are destroyed (even subtly), the continuity of identity might be lost, even if “you” are rebuilt.

  4. Legal and Ethical Uncertainty: By the time revival is technologically possible, there may be complex issues surrounding identity, rights, and societal integration.

Speculative Timeline

This is where we must tread carefully. Based on current progress, a plausible "optimistic" window for solving cryonics revival might be:

  • Not before 2100.

  • Possibly 2150–2300, assuming breakthroughs in:

    • Advanced nanotechnology,

    • Full brain emulation (or equivalent),

    • Reversible cryopreservation of a mammalian brain (first milestone),

    • And continued AI acceleration.

Ray Kurzweil’s projections in The Singularity Is Near suggest that by 2045, we might see "superintelligence" capable of medical miracles—but even in that optimistic framework, full revival from cryopreservation is not a certainty.

Bottom Line

It’s not unreasonable to hope—but it’s crucial to recognize the leap of faith involved. Your bet is on several simultaneous revolutions: in medicine, AI, materials science, neuroscience, and ethics. If even a few go further than expected, your hope could become more than just science fiction.

Would you like a visual timeline or roadmap showing the milestones likely needed for revival to become feasible?

Anti Aging and brain booster stack 10 May 2025 - 08:59 AM

Hi,
My regimen is

GEROVITAL H3 Injections Zentiva - 3 vials Monday Wednesday Friday - 12 Injections/ month

Cerebrolysin 5ml - 2 vials Tuesday / Thursday

Memotal Zentiva - piracetam - 1 vial / week

Cebrium Ever Pharma - 2 tablets/ day

and the most important to boost all of these
CEBRAOPTIM - 3 caps daily

Myers cocktail PharmaLife Laboratories - 5 infusions × 20ml

1 user(s) are viewing this feed (in the past 15 minutes)

0 members, 1 guests, 0 anonymous users